TrialAntimicrobial agents and chemotherapy2018

Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Rong Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.